David Stephens
Florida startup raises 2.5M to study medical benefits of psilocybinAugust 16, 2021
NeuroMetrix Quell designated breakthrough device by FDA for treating fibromyalgiaAugust 6, 2021
Harvard Law School Research Initiative Focuses on Psychedelics and the LawAugust 3, 2021
NeuroPace awarded $9M grant to study treatment of epilepsyAugust 2, 2021
Yale Study Shows how Psilocybin helps depressionJuly 29, 2021
Crowd-funded headphones monitor brain waves to keep you focusedJuly 28, 2021
Neurostimulation implant aims to cure back pain without invasive surgeryJuly 15, 2021
Merck and neuroloop are working together to treat inflammation with neurostimulationJuly 14, 2021
